• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAdagene
    Picture of Adagene logo

    ADAG — Adagene News Story

    $3.940.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    • Market Cap
      $186.70m
    • Enterprise Value
      $118.29m
    • Revenue
      $7.67m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ADAG Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ADAG Dividends
    All News

    NASDAQ RESUMED AT 09:38 AM

    Picture of Adagene logoAdagene
    01/09/2021 14:38
    NASDAQ RESUMED  ADAG.O  AT 09:38 AM
    

    Recent news on Adagene

    See all news
    • Brief: Adagene Inc Announces Offering Of American Depositary Shares

      02/04/2026 13:15
    • Brief: Adagene Announces FDA Fast Track Designation For Muzastotug (Adg126)

      16/12/2025 12:06
    • Brief: Adagene Expands SAFEBody Deal With Exelixis To Develop Third Novel Masked Antibody-Drug Conjugate

      16/09/2025 13:26
    • Brief: Adagene Inc - Partners With Conjugatebio For Antibody Drug Conjugate Development

      08/07/2025 12:25
    • Brief: Adagene Announces Up To $25 Million Strategic Investment From Sanofi

      01/07/2025 12:03

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.